ACR Provides Policy Guidance to HHS on Clinical AI

ACR® filed comments to HHS in response to its Request for Information (RFI)  regarding clinical AI adoption. In its filing, ACR outlined key actions HHS should take to strengthen regulation, payment policy and research supporting the safe use of AI in patient care. 

ACR recommended that HHS increase research investments and enhance regulatory oversight of AI-enabled medical devices and non-devices to support good AI governance, model transparency and post-deployment monitoring in clinical settings. ACR highlighted several ACR Data Science Institute® (DSI) programs designed to support safe and effective implementations of clinical AI.

The College also stressed the need to have sustainable Medicare reimbursement policies that support access to clinically valuable AI tools, encourage fair competition, recognize physician activities and ensure value-based integration of AI into patient care. 

HHS will use feedback to inform future department-wide activities that support the rapid adoption and use of AI in clinical care.

For questions about AI regulatory issues, contact Michael Peters, ACR Senior Director, Government Affairs, or Lindsay Robbins, ACR Regulatory Policy Specialist. For questions about AI reimbursement policy, contact Christina Berry, Manager, Economic Policy.